Organoid-Immune Cell Co-culture for Stable Live Imaging

Nathalia Ferreira1, Frauke Alves1,2, Andrea Markus3

  • 1Translational Molecular Imaging, Max-Planck-Institute for Multidisciplinary Sciences, Göttingen, Germany.

Insights

Patient-derived organoids (PDOs) offer personalized drug testing by modeling tumor heterogeneity. A new 3D co-culture method enables live imaging of PDOs with immune cells for immunotherapy assessment.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Patient-derived organoids (PDOs) are valuable ex vivo models for personalized cancer drug testing.
  • PDOs mimic tumor genetic and phenotypic diversity, aiding chemotherapy response studies.
  • Current PDO models lack immune components, limiting their utility for immunotherapy research.

Purpose of the Study:

  • To develop a protocol for co-culturing PDOs with immune cells for live-cell imaging.
  • To enable real-time assessment of immunotherapeutic effects on tumor organoids.

Main Methods:

  • Generation of PDOs from human tumor samples.
  • Co-culture of PDOs with HLA-matched peripheral blood mononuclear cells (PBMCs).
  • Utilizing a fixed Z-plane for stable live-cell imaging of the 3D co-culture system.

Main Results:

  • Successful establishment of a 3D co-culture system integrating PDOs and PBMCs.
  • Facilitation of stable live-cell imaging for real-time monitoring.
  • Demonstration of a method to assess immune cell interactions with tumor organoids.

Conclusions:

  • This novel co-culture protocol advances PDO utility for immunotherapy research.
  • The method allows for dynamic, real-time evaluation of therapeutic responses in a complex tumor microenvironment model.
  • This approach holds promise for accelerating the development of personalized immunotherapies.

Related Concept Videos